Holen Sie sich die Stockscreener-App
86.57
6.09%
4.97
Handel nachbörslich:
87.01
0.44
+0.51%
Schlusskurs vom Vortag:
$81.60
Offen:
$82.01
24-Stunden-Volumen:
881.09K
Relative Volume:
1.28
Marktkapitalisierung:
$4.47B
Einnahmen:
$379.25M
Nettoeinkommen (Verlust:
$-77.34M
KGV:
-53.70
EPS:
-1.6122
Netto-Cashflow:
$-27.87M
1W Leistung:
+10.89%
1M Leistung:
+32.37%
6M Leistung:
+61.93%
1J Leistung:
+106.12%
1-Tages-Spanne:
$81.62
$86.79
1-Wochen-Bereich:
$73.82
$86.79
52-Wochen-Spanne:
$36.88
$86.79
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Firmenname
Mirum Pharmaceuticals Inc
Sektor
Branche
Telefon
650-667-4085
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Vergleichen Sie MIRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
86.57 | 4.22B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | TD Cowen | Buy |
| 2025-08-11 | Fortgesetzt | Stifel | Buy |
| 2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-04-17 | Eingeleitet | Stifel | Buy |
| 2023-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-11-13 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-17 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-09-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2021-09-20 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-25 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-12 | Eingeleitet | Citigroup | Buy |
| 2019-08-12 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-12 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
Mirum Pharmaceuticals begins Phase 2 trial for Fragile X syndrome drug - Investing.com
Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals - Business Wire
Is Mirum Pharmaceuticals Inc. (08D) stock undervalued after correctionJuly 2025 Institutional & Risk Managed Investment Entry Signals - ulpravda.ru
Will Mirum Pharmaceuticals Inc. stock benefit from infrastructure spendingWeekly Stock Report & Risk Controlled Daily Plans - ulpravda.ru
How supply chain issues affect Mirum Pharmaceuticals Inc. stockJuly 2025 Action & Fast Gaining Stock Reports - ulpravda.ru
Can Mirum Pharmaceuticals Inc. stock reach $100 price targetQuarterly Profit Review & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Can Mirum Pharmaceuticals Inc. (08D) stock test all time highsShare Buyback & AI Enhanced Trading Signals - ulpravda.ru
Mirum Pharmaceuticals to raise $68.5M in private placement with TCGX - MSN
Mirum Pharmaceuticals stock hits all-time high at 82.65 USD By Investing.com - Investing.com Nigeria
How Investors May Respond To Mirum Pharmaceuticals (MIRM) Expanding Livmarli And Gaining J.P. Morgan Spotlight - Yahoo Finance
Is Mirum Pharmaceuticals Inc. stock supported by strong fundamentalsInstitutional Holding Changes & High Return Investment Plans - ulpravda.ru
Mirum Pharmaceuticals, Inc.common stock (NQ: MIRM - FinancialContent
How Mirum Pharmaceuticals Inc. stock compares to growth peersMorning Star Patterns & Free Skyrocketing Profit Margins - ulpravda.ru
Should you invest in Mirum Pharmaceuticals (MIRM)? - MSN
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Mirum Pharmaceuticals stock hits all-time high at 82.65 USD - Investing.com India
What hedge fund activity signals for Mirum Pharmaceuticals Inc. stockEarnings Date Calendar & Low Cost Trading Plans - ulpravda.ru
Mirum Pharmaceuticals (MIRM) price target increased by 16.25% to 104.35 - MSN
Should You Invest in Mirum Pharmaceuticals (MIRM)? - Insider Monkey
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 36.45% Potential Upside Captivates Investors - DirectorsTalk Interviews
Gains Recap: Will Mirum Pharmaceuticals Inc stock benefit from infrastructure spendingWeekly Investment Summary & Short-Term High Return Strategies - moha.gov.vn
Mirum Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update - ADVFN
Mirum Pharmaceuticals Earnings Notes - Trefis
Mirum Pharmaceuticals (NASDAQ:MIRM) Downgraded by Wall Street Zen to "Buy" - MarketBeat
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update - ADVFN
Aug Reactions: Will Mirum Pharmaceuticals Inc. stock pay special dividendsStop Loss & Reliable Volume Spike Alerts - moha.gov.vn
Price-Driven Insight from (MIRM) for Rule-Based Strategy - Stock Traders Daily
MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Shows Strong Growth Momentum and Bullish Technical Setup - Chartmill
Prediction: 3 Stocks That Will Be Worth More Than Newsmax 5 Years From Now - Finviz
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line - Yahoo Finance
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line - The Motley Fool
Rice Hall James & Associates LLC Sells 67,247 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals price target raised to $88 from $80 at Baird - MSN
What Analysts Think Is Changing the Story for Mirum Pharmaceuticals Now - Yahoo Finance
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Mirum pharmaceuticals director Saira Ramasastry sells $400k in shares By Investing.com - Investing.com Nigeria
Mirum Pharma director Grey sells $3.9 million in stock By Investing.com - Investing.com Nigeria
Mirum pharmaceuticals director Saira Ramasastry sells $400k in shares - Investing.com
Mirum Pharmaceuticals Executives Sell Shares - TradingView — Track All Markets
Mirum Pharma director Grey sells $3.9 million in stock - Investing.com
This Biotech Name Outperforms 93% Of Stocks, And It's In A Buy Zone - Investor's Business Daily
Mirum Pharmaceuticals joins elite list of stocks with 95-plus composite rating - MSN
Guidance Update: Will Mirum Pharmaceuticals Inc 08D stock sustain uptrend momentumPortfolio Return Summary & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Mirum Pharmaceuticals: Rich In 2025, Richer (In Promise) In 2026? I Believe So (MIRM) - Seeking Alpha
Mirum: Maintaining Buy Rating On VOLIXIBAT PSC Treatment Data Q2 2026 (NASDAQ:MIRM) - Seeking Alpha
Squarepoint Ops LLC Decreases Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
How (MIRM) Movements Inform Risk Allocation Models - Stock Traders Daily
Can Mirum Pharmaceuticals Inc. stock maintain growth trajectoryTrade Risk Summary & Real-Time Market Trend Scan - Улправда
Signal Recap: Will Mirum Pharmaceuticals Inc. (08D) stock hit Wall Street targets2025 Market WrapUp & Verified Momentum Watchlists - Улправда
Will Mirum Pharmaceuticals Inc. stock pay special dividends2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - Улправда
Mirum Pharmaceuticals Surges Following Strategic Moves and Analyst Ratings - timothysykes.com
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mirum Pharmaceuticals Inc-Aktie (MIRM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ramasastry Saira | Director |
Dec 22 '25 |
Sale |
80.00 |
5,000 |
400,000 |
0 |
| GREY MICHAEL G | Director |
Dec 19 '25 |
Option Exercise |
2.94 |
50,000 |
146,800 |
50,000 |
| GREY MICHAEL G | Director |
Dec 19 '25 |
Sale |
78.00 |
50,000 |
3,900,000 |
0 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):